333954-86-2

Basic information

• Product Name: tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate
• Synonyms: tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate;4-(1-BOC-Piperidin-4-yloxy)benzonitrile
• CAS NO: 333954-86-2
• Molecular Formula: C₁₇H₂₂N₂O₃
• Molecular Weight: 302.36818
• Mol File: 333954-86-2.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate(333954-86-2)
• EPA Substance Registry System: tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate(333954-86-2)

Safety Data

• Hazardous Substances Data: 333954-86-2(Hazardous Substances Data)

Usage

General Description

Tert-butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate is a chemical compound with the molecular formula C19H25N3O3. It is a piperidine derivative that contains a tert-butyl group, a cyanophenoxy group, and a carboxylate group. tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate is often used in pharmaceutical research and drug discovery as it has potential applications in the development of new medications. The precise properties and uses of tert-butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate may vary depending on the specific research or manufacturing processes it is involved in.

Upstream product

• 623-03-0 4-Cyanochlorobenzene 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 767-00-0 4-cyanophenol 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 1194-02-1 4-fluorobenzonitrile 
• 118811-07-7 tert-butyl 4-(tosyloxy)piperidin-1-carboxylate 

Downstream Products

• 685565-26-8 4-(4-piperidinyloxy)benzonitrile trifluoroacetate 
• 397275-27-3 4-((1-cyclobutylpiperidin-4-yl)oxy)benzonitrile 
• 1394808-23-1 N-[4-(1-cyclobutylpiperidin-4-yloxy)benzyl]morpholine-4-ylamide 
• 1394808-77-5 4-(1-cyclobutyl piperidin-4-yloxy)benzylamine 
• 769119-29-1 4-((1-cyclobutylpiperidin-4-yl)oxy)benzoic acid 
• 1087161-30-5 methyl 4-((1-cyclobutylpiperidin-4-yl)oxy)benzoate 
• 870997-68-5 4-((1-cyclobutylpiperidin-4-yl)oxy)benzaldehyde 
• 333954-90-8 4-(4-cyanophenoxy)piperidine· hydrochloride 
• 609781-33-1 4-(4-carbamoyl-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester 
• 528861-47-4 tert-butyl 4-[4-(1H-tetrazol-5-yl)phenoxy]-1-piperidinecarboxylate 
• 397277-60-0 4-((1-benzylpiperidin-4-yl)oxy)benzonitrile 

Relevant articles and documents

NOVEL OXADIAZOLES

The present invention relates to novel compound of Formula I, wherein, R1, A1, A2, A3, A4, A5, L1, A, L2 and R2 are as defined in the detailed description. The present invention also relates to a combination or a composition comprising the compound of Formula I.

MULTIPLE D2 A(NTA)GONISTS/H3 ANTAGONISTS FOR TREATMENT OF CNS-RELATED DISORDERS

The present invention relates to compounds compound according to Formula (III); and pharmaceutically acceptable salts, hydrates and solvates thereof. These compounds have D2receptor antagonist/(partial) agonist effects and H3antagonistic effects, pharmaceutical compositions thereof, and methods of using them for application in the prophylaxis or treatment of CNS disorders.

NOVEL COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS

The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pha